Impact of Fludrocortisone on the Outcomes of Subarachnoid Hemorrhage Patients: A Retrospective Analysis.
Akshitkumar M MistryJanki NaidugariMichael J FeldmanJordan A MagarikDale DingIsaac J AbecassisMatthew W SemlerTodd W RicePublished in: medRxiv : the preprint server for health sciences (2023)
The risk of disability or death at 90 days was lower with the use of fludrocortisone in aSAH patients.